Notch Signalling: A Potential Therapeutic Pathway in Oral Squamous Cell Carcinoma

Ankit Pandey, Sreeshma Bhuvanadas, Joel P. Joseph, Rama Jayaraj, Arikketh Devi

Research output: Contribution to journalReview articlepeer-review


Cancer, a set of diseases characterized by abnormal cell growth resulting from alteration in the expression pattern of diverse genes, is one of the prominent causes of mortality and morbidity worldwide. This modification of various genes leads to altered signalling cascades and changes in the molecular network. These changes eventually give rise to cellular dysfunction and then to systemic failure causing death. Of the several pathways that are aberrantly activated in cancer, Notch signalling pathway is a prominent one. Notch signalling pathway is a juxtracrine signalling pathway which activates the genes associated with cell proliferation, survival and angiogenesis. Notch signalling pathway components are seen to be upregulated in several types of cancer. Oral Squamous Cell Carcinoma (OSCC) is a predominant category of oral cancer where aberrant activation of Notch signalling causes tumour progression and metastasis. In this review, we discuss the Notch signalling pathway, its components, forms and its role in the progression and metastasis of oral squamous cell carcinoma.

Original languageEnglish
Pages (from-to)2159-2168
Number of pages10
JournalEndocrine, Metabolic and Immune Disorders - Drug Targets
Issue number12
Publication statusPublished - Dec 2021


Dive into the research topics of 'Notch Signalling: A Potential Therapeutic Pathway in Oral Squamous Cell Carcinoma'. Together they form a unique fingerprint.

Cite this